Skip to content

A New Assistive Intervenrion Model Study of Extracorporeal Shockwave Therapy Combined with Kinesio Taping on the Promotion of Senile Primary Sarcopenia Rehabilitation Efficacy

A New Assistive Intervenrion Model Study of Extracorporeal Shockwave Therapy Combined with Kinesio Taping on the Promotion of Senile Primary Sarcopenia Rehabilitation Efficacy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064269
Enrollment
Unknown
Registered
2022-10-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

senile primary sarcopenia

Interventions

extracorporeal shockwave therapy+kinesio taping+routine resistive training group (experimental group):extracorporeal shockwave therapy
extracorporeal shockwave therapy+kinesio taping+routine resistive training group (experimental group):kinesio taping
sham shockwave therapy+sham taping+routine resistive training group (control group):sham shockwave therapy
sham shockwave therapy+sham taping+routine resistive training group (control group):sham taping

Sponsors

Shanghai First People's Hospital/Shanghai General Hospital, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 60 years old to 75 years old (inclusive), all meet the diagnostic criteria of the Asian Sarcopenia Working Group in 2019: muscle index <7.0kg/m^2 for men and <5.4kg/m^2 for women; slow pace, all within 0.8m/s or less; 2. no habit of regular physical exercise; 3. voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. secondary sarcopenia caused by diseases; 2. thrombosis in the limbs; 3. corresponding skin diseases, such as acute neurodermatitis or psoriasis; 4. tendency of tension blisters before treatment; 5. combined with primary diseases that affect muscle strength: such as cerebrovascular disease, spinal cord injury, myasthenia gravis, etc.; 6. application of muscle relaxants within 24 hours before enrollment; 7. shock wave intolerance, patch material (acrylic acid, etc.) allergic.

Design outcomes

Primary

MeasureTime frame
skeletal muscle index;

Secondary

MeasureTime frame
walking speed;biceps femoris and quadriceps femoris muscle strength;biceps femoris and quadriceps femoris static muscle tension;serum insulin growth factor-1 level;

Countries

China

Contacts

Public ContactBo Yu

Shanghai First People's Hospital/Shanghai General Hospital, Shanghai Jiaotong University

yubo@vip.163.com+86 13901807928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026